Varicocele Clinical Trial
— OCCLUDE-IOfficial title:
PrOspective, MultiCenter Study for the Evaluation of PerformanCe of the ArtVentive Medical Group Peripheral EndoLuminal OcclUsion SystemTM in the Treatment of Varicocele or Pelvic Congestion SynDromE - OCCLUDE I
To collect confirmatory data in support of the safety and performance of the ArtVentive Medical Group Endoluminal Occlusion System.
Status | Enrolling by invitation |
Enrollment | 40 |
Est. completion date | January 2016 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: 1. Subjects aged =18 to =75 years. 2. Subject with target vessels of 3.0 mm to 12.0 mm in diameter. 3. Subject having indications to undergo embolotherapy consistent with clinical and pre-procedural angiographic assessment for spermatic vein origin varicocele (unilateral and/or bilateral) or pelvic congestion syndrome (pelvic venous incompetence). 4. Subject is able and willing to comply with site standard medical follow-up, including one month follow-up visit. 5. Subject or subject's legal representative have been informed of the nature of the study, agrees to participate and has signed the consent form. Exclusion Criteria: 1. Subject has an active systemic infection. 2. Subject has a known allergy to iodinated contrast for which they cannot be adequately premedicated. 3. Subject has history of stroke within the prior 6 months. 4. Subject has history of myocardial infarction with the prior 3 months. 5. Subject has acute or chronic renal disease (e.g., as measured by a serum creatinine of >2.5 mg/dL or >220 umol/L), or on dialysis. 6. Subject has a known coagulopathy or has a bleeding diatheses, thrombocytopenia with platelet count less than 100,000/microliter, or INR >1.5. 7. Co-morbid conditions that place the subject at an unacceptable surgical risk (e.g., severe chronic obstructive pulmonary disease, hepatic failure, cardiac disease, autoimmune disorders or conditions of severe immunosuppression). 8. Subjects in whom venography or arteriography is contraindicated. 9. Subjects with known hypersensitivity or contraindication to nickel or nitinol. 10. Subject has a less than one year life expectancy. 11. Subject is pregnant or breastfeeding. 12. Subject with endometriosis or other ovarian / uterine pathology with adhesions that would interfere with the endpoints of this study. 13. Subject with previous pelvic surgical intervention or embolotherapy for varicocele or ovarian varices that would interfere with the endpoints of this study, including but not limited to, recurrent varicocele or ovarian varices. 14. Any clinical evidence that the investigator feels would place the subject at increased risk with the deployment of the device. 15. Subject has planned concomitant procedure at the time of the embolization (e.g., coil embolization, etc.). 16. Subject is participating in another study of a device, medication, biologic, or other agent within 30 days or could, in the opinion of the investigator, impact the results of this study. 17. Subject has other medical, social or psychological problems that in the opinion of the investigator would preclude them from receiving this treatment and the procedures and or participating in evaluations pre- and post-treatment. |
Observational Model: Case-Only, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Belgium | UZ Leuven | Leuven | |
Poland | University Hospital No4 | Lubin | |
Switzerland | Ospedale Regionale di Lugano | Lugano |
Lead Sponsor | Collaborator |
---|---|
ArtVentive Medical Group, Inc. |
Belgium, Poland, Switzerland,
Venbrux AC, Rudakov L, Plass A, Emmert MY, Ebner A. A new occlusion device: application of the ArtVentive endoluminal occlusion system (EOS)--first in human clinical trial. Cardiovasc Intervent Radiol. 2014 Feb;37(1):85-93. doi: 10.1007/s00270-013-0626-y. Epub 2013 May 24. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Safety | Composite of new-onset major device-related adverse event(s) including device embolization beyond targeted treatment area (not therapeutic indication of embolization), need for emergency surgical intervention of the target vessel, or distal embolization (non-device embolization, e.g., particulate matter / plaque distal to the device) at 30 days. | Acute & 30 days | Yes |
Secondary | Pain | Reduction of pain. | Acute & 30 days | No |
Secondary | Recurrent varices | Recurrence of varices requiring repeat embolizations within 30 days. | 30 days | Yes |
Secondary | Occlusion | Sustained occlusion at 30 days follow-up. | 30 days | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00639899 -
The Effect of Spermatic Vein Embolization on Prostatic Hypertrophy
|
N/A | |
Not yet recruiting |
NCT03281915 -
the Effect of Different Modialites of Varicocelectomy on Semen Parameters in Patient With Normal Semen Analysis
|
N/A | |
Recruiting |
NCT03540056 -
Testicular Growth During Puberty in Boys With and Without a Left-sided Varicocele
|
||
Completed |
NCT02983656 -
Analysis on AEFI Surveillance Data for Live Attenuated Varicella Vaccine
|
N/A | |
Enrolling by invitation |
NCT05617261 -
Evaluating Patient Tolerability and Success for Penile and Scrotal Urologic Procedures Under Conscious Sedation: A Prospective Study
|
||
Not yet recruiting |
NCT05330533 -
Effect of Recent Ejaculation on Scrotal Duplex Parameters in Infertile Males With Varicocele
|
||
Not yet recruiting |
NCT03090438 -
IVF Outcomes After Varicocele Repair
|
N/A | |
Completed |
NCT02401087 -
The Anaesthesiological Approach to Varicocele Correction in Outpatients Setting: an Observational Analysis
|
||
Completed |
NCT00044369 -
Role of the Toxic Metal Cadmium in the Mechanism Producing Infertility With a Varicocele
|
N/A | |
Completed |
NCT05034406 -
The Effect of Subcutaneous and Intraperitoneal Anesthesia on Post Laparoscopic Pain
|
N/A | |
Completed |
NCT03477149 -
EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications
|
N/A | |
Not yet recruiting |
NCT05171504 -
Lactoferrin and Iron in Seminal Plasma of Varicocele
|
||
Completed |
NCT02335385 -
Single Incision Laparoscopic Varicocelectomy
|
N/A | |
Not yet recruiting |
NCT03341897 -
Varicocele Treatement by Endovasculer Embolization
|
N/A | |
Active, not recruiting |
NCT03079609 -
The Search for Viral and Bacterial Etiology of Varicocele
|
N/A | |
Not yet recruiting |
NCT02719093 -
Role of FSHR Polymorphism p.N680S in the Therapy With FSH in Patients Who Underwent Varicocele Surgery
|
Phase 4 | |
Recruiting |
NCT02695199 -
Doppler Ultrasound Assisted Varicocelectomy Improve Sperm Qualities
|
N/A | |
Recruiting |
NCT02304575 -
Quality of Life Among Testicular Cancer Survivors
|
N/A | |
Completed |
NCT01463787 -
Comparison of Outcomes of Two Approaches in Microsurgical Varicocelectomy in Chinese Infertile Males: A Prospective Randomized, Controlled Trial
|
Phase 4 | |
Completed |
NCT01259258 -
Dye Assisted Lymphatic Sparing Subinguinal Varicocelectomy
|
Phase 2 |